July 31 (Reuters) - Mettler-Toledo International MTD.N raised its profit forecast for the year on Thursday, after posting better-than-expected second-quarter results, driven by strong demand for its laboratory instruments used in drug development.

The Columbus, Ohio-based company forecast 2025 adjusted profit in the range of $42.10 to $42.60 per share, compared with its previous projection of $41.25 to $42. Analysts were expecting a profit of $41.60 per share, according to data compiled by LSEG.

The company said its full-year forecast accounts for a 4% impact from earlier shipping delays and an additional 4% drag from higher tariffs, although it expects most of the tariff costs to be offset by mitigation efforts this year.

Mettler-Toledo also said that it was now expecting third-quarter adjusted profit in the range of $10.55 to $10.75 per share, compared with estimates of $10.47 apiece.

The firm's second-quarter sales came in at $983.22 million, surpassing analysts' estimate of $957.9 million.

On an adjusted basis, Mettler-Toledo earned a profit of $10.09 per share for the quarter ending June 30, topping analysts' estimates of $9.61 each.

The company designs and produces precision instruments, including laboratory balances, industrial scales, analytical instruments, and product inspection systems, which are used across sectors like pharmaceuticals, food processing, and chemicals.

(Reporting by Padmanabhan Ananthan in Bengaluru; Editing by Anil D'Silva)

((Padmanabhan.Ananthan@thomsonreuters.com;))